Literature DB >> 15223230

Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).

Masako Tomihira1, Eiji Kawasaki, Hiromu Nakajima, Yutaka Imamura, Yuichi Sato, Michio Sata, Masayoshi Kage, Hideo Sugie, Kiyohide Nunoi.   

Abstract

We report a 19-year-old woman who had a history of type 1 diabetes with recurrent glycogen accumulation in the liver. During her infantile period she presented with no hepatomegaly nor growth retardation. On admission she was diagnosed with diabetic ketoacidosis (DKA). She also had hepatomegaly and elevated transaminase levels, but these abnormalities had resolved after administration of insulin. However, 4 weeks after DKA marked hepatomegaly and elevated transaminases were reappeared with simultaneous hypoglycemia which suggested an impaired glycogenolysis in the extraordinary conditions. We supposed the partial deficiency of liver glycogen phosphorylase activity in this patient and analyzed the liver glycogen phosphorylase gene (PYGL). Deduced amino acid sequence of the PYGL in this patient was completely identical to that reported by Burwinkel et al. (Y15233), however, the nucleotide sequence of PYGL cDNA was heterozygous for substitutions at positions Asp339 (GAT to GAC) on exon 9 and Ala703 (GCT to GCC on exon 17, respectively. These SNPs were also screened in 51 Japanese normal subjects by PCR-based direct sequencing or PCR-RFLP method. The same genotype observed in this patient was detected in 2 of 51(3.9%) normal subjects. These results suggest that the structure of PYGL coding sequence in this patient is unlikely to account for her excessive liver glycogen accumulation. Further studies including genetic analysis on the promoter region of the gene are necessary to clarify the etiology of susceptibility to excessive liver glycogen storage in patients with type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223230     DOI: 10.1016/j.diabres.2003.12.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus.

Authors:  Hwal Rim Jeong; Young Seok Shim; Young Bae Kim; Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

2.  Elevated lactate in Mauriac syndrome: still a mystery.

Authors:  Brice Touilloux; Henri Lu; Belinda Campos-Xavier; Andrea Superti-Furga; Michael Hauschild; Thérèse Bouthors; Christel Tran
Journal:  BMC Endocr Disord       Date:  2021-08-21       Impact factor: 2.763

3.  Starvation-induced true diabetic euglycemic ketoacidosis in severe depression.

Authors:  Franklin Joseph; Lydia Anderson; Niru Goenka; Jiten Vora
Journal:  J Gen Intern Med       Date:  2008-10-31       Impact factor: 5.128

Review 4.  Glycogenic hepatopathy: A narrative review.

Authors:  Jagannath M Sherigar; Joline De Castro; Yong Mei Yin; Debra Guss; Smruti R Mohanty
Journal:  World J Hepatol       Date:  2018-02-27

5.  Glycogenic Hepatopathy in Type 1 Diabetes Mellitus.

Authors:  Shohei Asada; Hideto Kawaratani; Tsuyoshi Mashitani; Daisuke Kaya; Maiko Nishigori; Takuya Kubo; Yasuhiko Sawada; Yukihisa Fujinaga; Kosuke Kaji; Mitsuteru Kitade; Tadashi Namisaki; Kei Moriya; Akira Mitoro; Hitoshi Yoshiji
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

6.  Re: Glycogen hepatopathy in a 13-year-old male with type 1 diabetes.

Authors:  Mahmood Al-Mendalawi
Journal:  Ann Saudi Med       Date:  2012 Jul-Aug       Impact factor: 1.526

Review 7.  Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.

Authors:  Adeboye Olakunle Bamgboye; Isaac Oluwadamilare Oni; Andrew Collier
Journal:  Eur J Clin Pharmacol       Date:  2020-11-26       Impact factor: 2.953

8.  The fungus Ustilago maydis and humans share disease-related proteins that are not found in Saccharomyces cerevisiae.

Authors:  Martin Münsterkötter; Gero Steinberg
Journal:  BMC Genomics       Date:  2007-12-20       Impact factor: 3.969

9.  Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose-response and curative effects study.

Authors:  Weiwei Feng; Guanghua Mao; Qian Li; Wei Wang; Yao Chen; Ting Zhao; Fang Li; Ye Zou; Huiyu Wu; Liuqing Yang; Xiangyang Wu
Journal:  J Diabetes Investig       Date:  2015-04-15       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.